2023 Life Science Review Award
CAMBRIDGE, MA, MARCH 2023: Matterworks has been recognized in the Top 10 Biotech Startups - 2023 by Life Science Review.
Matterworks Announces CEO Appointment and Board Updates
CAMBRIDGE, MA, DECMBER 2022: Matterworks, Inc., developers of the world's most powerful AI platform for modeling real-time biology to accelerate the discovery, development, and manufacturing of life sciences technologies, including biologics and gene therapies, today announces CEO appointment and updates to its Board of Directors.
Matterworks Awarded NIIMBL Project 5.2 Grant
CAMBRIDGE, MA, AUGUST 2022: Matterworks is awarded a grant to participate in NIIMBL Project 5.2. With support from Eli Lilly and Sartorius our novel AI-powered Pyxis™ Metabolomics Platform will demonstrate biological insight in bioprocessing through the rapid, absolute quantitation of critical metabolites that impact titer and CQAs.
Matterworks Announces Updates To Its Board Of Directors
CAMBRIDGE, MA, APRIL 2022: Matterworks, Inc., developers of the world’s most powerful metabolomics platform, which accelerates the discovery, development, and manufacturing of biologics and gene therapies, today announces updates to its Board of Directors.